株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の感染症分子診断薬市場:各国市場の将来動向、サプライヤーの市場シェア、新規技術、競争環境

2016 Infectious Disease Molecular Diagnostics Market: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review

発行 Venture Planning Group 商品コード 308575
出版日 ページ情報 英文 775 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=115.18円で換算しております。

Local License: 同一事業所内

Back to Top
世界の感染症分子診断薬市場:各国市場の将来動向、サプライヤーの市場シェア、新規技術、競争環境 2016 Infectious Disease Molecular Diagnostics Market: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review
出版日: ページ情報: 英文 775 Pages
概要

当レポートでは、世界の主要国(米国、欧州5ヶ国、日本)における感染症向け分子診断薬市場について分析し、技術・市場の最新状況や、全世界および各国の市場規模・シェアの動向(今後5年間分)、将来的な市場機会、想定される市場リスク、主要企業のプロファイルなどの情報をお届けいたします。

イントロダクション

世界市場の傾向と新規技術

  • DNAシーケンシング
  • DNA・RNAプローブ技術
  • 検知技術
  • 医療機器:自動/半自動解析装置の分析
  • バイオチップ:遺伝子センサー・マイクロアレイ・ラブオンチップ
  • 薬理ゲノミクス
  • 主な感染症の分子検査方法(全33種)
    • AIDS(後天性免疫不全症候群)
      • 背景事情
      • 診断検査
      • ワクチン・治療薬
    • アデノウイルス/アデノ関連ウイルス(AAV)
    • 炭疽病
    • バベシア症
    • BEAおよびその他のバルトネラ病
    • シャーガス病
    • カンピロバクター
    • クラミジア
    • クロイツェル・ヤコブ病
    • サイトメガロウイルス
    • エボラウイルス
    • エコーウイルス
    • 脳炎
    • エンテロウイルス
    • エプスタイン・バー(EB)ウイルス
    • 淋病
    • A・ B・C・D・E・G型肝炎
    • 単純ヘルペスウイルス
    • レジオネラ
    • ライム病
    • マラリア
    • マイコプラズマ
    • パピロマウイルス(HPV)
    • パルボウイルスB19
    • 肺炎
    • ポリオーマウイルス
    • サルモネラ菌
    • 細菌性赤痢
    • 連鎖球菌A・B
    • トキソプラスマ症
    • 結核
    • 西ナイルウイルス
    • エルセニア
  • 競合/保管技術
  • 世界市場の概況
    • ビジネス環境
    • 市場構造
    • 市場規模・成長率

フランス市場

  • エグゼクティブ・サマリー
  • ビジネス環境
  • 市場構造
  • 市場のダイナミクス・傾向・規模・成長率
    • 市場規模の予測値:検査項目・市場分野別
    • 売上高の予測値:検査項目・市場分野別
    • 主要サプライヤーの売上高と市場シェア

ドイツ市場

イタリア市場

日本市場

スペイン市場

英国市場

米国市場

主な製品開発の機会

  • 新たな医療機器の市場機会
  • 新たな試薬キット・検査装置/パネルの市場機会
  • 新規IT・コンピューター・ソフトウェア・自動化の市場機会
  • 新たな付属装置の市場機会

分散検査製品の設計基準

代替的な市場普及戦略

潜在的な参入障壁とリスク

企業プロファイル

  • Abbott
  • Affymetrix
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca/Nuvelo
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • BioMerieux
  • Bio-Rad
  • Biotes
  • Caliper
  • Cepheid
  • Decode
  • Diadexus
  • 栄研化学
  • Enzo
  • Exact Sciences
  • 富士レビオ/Innogenetics
  • Grifols
  • Hologic/Gen-Probe
  • Illumina
  • Kreatech
  • Li-Cor Biosciences
  • Life Technologies/Thermo Fisher
  • Monogram Biosciences
  • Myriad Genetics
  • Nanogen/Elitech
  • Orchid CellMark
  • Ortho-Clinical Diagnostics
  • Proteome Sciences
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • 島津製作所
  • Siemens
  • Sierra Molecular
  • タカラバイオ
  • Tecan Group

付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPMD20943

The report is available by country, section, market segment, individual test, and can be custom-tailored to your specific information needs and budget.

This new seven-country study from VPGMarketResearch contains 775 pages, 73 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years.

Report Highlights

- Business and technological trends in major markets Five-year test volume and sales forecasts Market shares of leading competitors Feature comparison of major analyzers Strategic profiles of leading market players and start-up firms developing innovative products Specific product and business opportunities for instrument and consumable suppliers.

Rationale

The infectious disease molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Geographic Coverage

- France Germany Italy Japan Spain UK USA

Worldwide Market Overview

- Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases by country and market segment.

- Five-year test volume and sales projections by country.

Market Segmentation Analysis

- Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components.

- Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays.

- A comprehensive analysis of the sequencing market by country and laboratory segment.

- Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers by country.

Product/Technology Review

- Comparison of leading infectious disease molecular diagnostic analyzers.

- Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods.

- Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products.

Competitive Assessments

- Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.

   - Abbott    - Affymetrix    - Agilent Technologies    - Applied Gene Technologies    - Arca Biopharma    - Beckman Coulter/Danaher    - Becton Dickinson    - Biokit    - BioMerieux    - Bio-Rad    - Biotest    - CellMark Forensics/LabCorp    - Cepheid    - Decode Genetics    - Diadexus    - Eiken    - Elitech Group    - Enzo    - Exact Sciences    - Fujirebio    - Grifols    - Hologic/Gen-Probe    - Illumina    - Kreatech/Leica    - Li-Cor Biosciences    - Monogram Biosciences    - Myriad Genetics    - Ortho-Clinical Diagnostics   - Perkin Elmer/Caliper Life Sciences    - Proteome Sciences    - Qiagen    - Roche    - Scienion    - Sequenom    - Shimadzu    - Siemens    - Sierra Molecular    - Takara Bio    - Tecan Group    - Thermo Fisher

- Comprehensive listings of companies developing and marketing infectious disease molecular diagnostic products, by test and application.

Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially significant market appeal during the next five years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

- Business planning issues and concerns.

Contains 775 pages and 73 tables

Table of Contents

Introduction

Global Market Trends and Emerging Technologies

  • A. DNA Sequencing
  • B. DNA And RNA Probe Technology
  • C. Detection Technologies
  • D. Instrumentation: Review of Automated and Semi-Automated Analyzers
  • E. Biochips: Genosensors, Microarrays, Labs-on-the-Chip
  • F. Pharmacogenomics
  • G. Major Molecular Infectious Diseases Tests

AIDS

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Adenovirus/Adeno-Associated Viruses (AAV)

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Anthrax/Bacillus Anthracis

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Babesiosis

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

BEA and Other Bartonella Diseases

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Chagas Disease

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Campylobacter

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Chlamydia

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Creutzfeldt-Jakob's Disease

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Cytomegalovirus

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Ebola Virus

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Echovirus

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Encephalitis

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Enteroviruses

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Epstein-Barr Virus

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Gonorrhea

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Hepatitis A, B, C, D, E, G

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Herpes Simplex Virus

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Legionella

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Lyme Disease

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Malaria

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Mycoplasma

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Papillomaviruses/HPV

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Parvovirus B19

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Pneumonia

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Polyomaviruses

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Salmonellosis

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Shigellosis

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Streptococci A, B

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Toxoplasmosis

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Tuberculosis

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

West Nile Virus

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

Yersinia

  • Background
  • Diagnostic Tests
  • Vaccines and Drugs

H. Competing/Complementing Technologies

I. Worldwide Market Overview

  • 1. Business Environment
  • 2. Market Structure
  • 3. Market Size and Growth

France

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Dynamics, Trends, Size and Growth
    • Volume Forecasts by Test and Market Segment
    • Sales Forecasts by Test and Market Segment
    • Major Supplier Sales and Market Shares

Germany

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Dynamics, Trends, Size and Growth
    • Volume Forecasts by Test and Market Segment
    • Sales Forecasts by Test and Market Segment
    • Major Supplier Sales and Market Shares

Italy

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Dynamics, Trends, Size and Growth
    • Volume Forecasts by Test and Market Segment
    • Sales Forecasts by Test and Market Segment
    • Major Supplier Sales and Market Shares

Japan

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Dynamics, Trends, Size and Growth
    • Volume Forecasts by Test and Market Segment
    • Sales Forecasts by Test and Market Segment
    • Major Supplier Sales and Market Shares

Spain

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Dynamics, Trends, Size and Growth
    • Volume Forecasts by Test and Market Segment
    • Sales Forecasts by Test and Market Segment
    • Major Supplier Sales and Market Shares

U.K.

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Dynamics, Trends, Size and Growth
    • Volume Forecasts by Test and Market Segment
    • Sales Forecasts by Test and Market Segment
    • Major Supplier Sales and Market Shares

U.S.A.

  • A. Executive Summary
  • B. Business Environment and Healthcare Reform
  • C. Market Structure
  • D. Market Dynamics, Trends, Size and Growth
    • Volume Forecasts by Test and Market Segment
    • Sales Forecasts by Test and Market Segment
    • Major Supplier Sales and Market Shares

Major Product Development Opportunities

  • A. Opportunities for New Instrumentation
  • B. Opportunities for New Reagent Kits and Test Systems/Panels
  • C. Opportunities for New IT, Computers, Software and Automation
  • D. Opportunities for New Auxiliary Products

Design Criteria For Decentralized Testing Products

Alternative Market Penetration Strategies

Potential Market Entry Barriers And Risks

Competitive Profiles

  • Abbott
  • Affymetrix
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca/Nuvelo
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • BioMerieux
  • Bio-Rad
  • Biotest
  • Caliper
  • Cepheid
  • Decode
  • Diadexus
  • Eiken
  • Enzo
  • Exact Sciences
  • Fujirebio/Innogenetics
  • Grifols
  • Hologic/Gen-Probe
  • Illumina
  • Kreatech
  • Li-Cor Biosciences
  • Life Technologies/Thermo Fisher
  • Monogram Biosciences
  • Myriad Genetics
  • Nanogen/Elitech
  • Orchid CellMark
  • Ortho-Clinical Diagnostics
  • Proteome Sciences
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • Shimadzu
  • Siemens
  • Sierra Molecular
  • Takara Bio
  • Tecan Group

Appendixes

List of Tables

  • Major Companies Developing or Marketing AIDS Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Adenovirus Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Campylobacter Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Chlamydia Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing CMV Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing EBV Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Hepatitis Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Herpes Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Legionella Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Papilloma Virus Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Pneumonia Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Salmonella Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Shigella Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Streptococci Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic And Other Direct Identification Tests
  • Worldwide, Laboratories Performing DNA Sequencing By Country
  • Worldwide, Molecular Diagnostics Market Potential Laboratory Universe by Country
  • Worldwide, Molecular Diagnostic Test Volume Forecast By Country
  • Worldwide, Molecular Diagnostics Market Forecast by Country
  • France, Laboratories Performing DNA Sequencing By Market Segment
  • France, Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
  • France, Major Infectious Disease Molecular Diagnostics Test Volume Forecast
  • France, Infectious Disease Screening NAT Volume Forecast
  • France, Infectious Disease Screening NAT Reagent Market Forecast by Test
  • France, Molecular Diagnostics Market By Major Supplier
  • France, HIV/Hepatitis NAT Market Reagent Sales By Major Supplier
  • Germany, Laboratories Performing DNA Sequencing by Market Segment
  • Germany, Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
  • Germany, Major Infectious Disease Molecular Diagnostics Test Volume Forecast
  • Germany, Infectious Disease Screening NAT Volume Forecast
  • Germany, Infectious Disease Screening NAT Reagent Market Forecast by Test
  • Germany, Molecular Diagnostics Market by Major Supplier
  • Germany, HIV/Hepatitis NAT Market Reagent Sales by Major Supplier
  • Italy, Laboratories Performing DNA Sequencing by Market Segment
  • Italy, Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
  • Italy, Major Infectious Disease Molecular Diagnostics Test Volume Forecast
  • Italy, Infectious Disease Screening NAT Volume Forecast
  • Italy, Infectious Disease Screening Nat Reagent Market Forecast by Test
  • Italy, Molecular Diagnostics Market By Major Supplier
  • Italy, HIV/Hepatitis NAT Market By Major Supplier
  • Japan, Laboratories Performing DNA Sequencing by Market Segment
  • Japan, Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
  • Japan, Major Infectious Disease Molecular Diagnostics Test Volume Forecast
  • Japan, Infectious Disease Screening NAT Volume Forecast
  • Japan, Infectious Disease Screening Nat Reagent Market Forecast by Test
  • Japan, Molecular Diagnostics Market By Major Supplier
  • Japan, HIV/Hepatitis NAT Market Reagent Sales by Major Supplier
  • Spain, Laboratories Performing DNA Sequencing by Market Segment
  • Spain, Molecular Diagnostics Market, Potential Laboratory Universe by Market Segment
  • Spain, Major Infectious Disease Molecular Diagnostics Test Volume Forecast
  • Spain, Infectious Disease Screening NAT Volume Forecast
  • Spain, Infectious Disease Screening Nat Reagent Market Forecast by Test
  • Spain, Molecular Diagnostics Market By Major Supplier
  • Spain, HIV/Hepatitis NAT Market Reagent Sales by Major Supplier
  • U.K., Laboratories Performing Dna Sequencing by Market Segment
  • U.K., Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
  • U.K., Major Infectious Disease Molecular Diagnostics Test Volume Forecast
  • U.K., Infectious Disease Screening NAT Volume Forecast
  • U.K., Infectious Disease Screening NAT Reagent Market Forecast by Test
  • U.K., Molecular Diagnostics Market by Major Supplier
  • U.K., HIV/Hepatitis NAT Market Reagent Sales by Major Supplier
  • U.S.A., Laboratories Performing DNA Sequencing by Market Segment
  • U.S.A., Molecular Diagnostics Market, Potential Laboratory Universe by Market Segment
  • U.S.A., Major Infectious Disease Molecular Diagnostics Test Volume Forecast
  • U.S.A., Infectious Disease Screening NAT Volume by Test Forecast
  • U.S.A., Infectious Disease Screening Nat Reagent Market Forecast by Test
  • U.S.A., Molecular Diagnostics Market by Major Supplier
  • U.S.A., HIV/Hepatitis C NAT Market Reagent Sales By Major Supplier
  • U.S.A., West Nile Virus NAT Market Reagent Sales By Major Supplier
Back to Top